Johnson & Johnson and three opioid distributors’ $26 billion deal to resolve thousands of lawsuits over their role in the addiction crisis shifts the focus to major pharmacies while setting a roadmap for future settlements, attorneys say.
McKesson Corp., Cardinal Health Inc., and AmerisourceBergen Corp. agreed to pay around $21 billion to resolve allegations that they looked the other way on opioid shipments, state attorneys general involved in the multifaceted litigation said Wednesday. J&J will pay $5 billion to fend off claims it illegally marketed opioids.
J&J and the distributors may see an end in sight, but companies ...
